Literature DB >> 22860284

Pradaxa, bleeding and tort litigation solicitation.

Greg Flaker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22860284      PMCID： PMC6179701     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


× No keyword cloud information.
  2 in total

1.  Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran.

Authors:  B Nhi Beasley; Ellis F Unger; Robert Temple
Journal:  N Engl J Med       Date:  2011-04-13       Impact factor: 91.245

2.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.